Use of comprehensive next-generation sequencing to identify pathogenic germline variants with therapeutic relevance in metastatic breast cancer.
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: U-M Rogel Cancer Center, University of Michigan, Michigan Medicine
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W3168922194
